share_log

Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

SEC ·  Nov 14, 2022 21:02
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.